K. Jarvie

发表

High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.

M. Caron, S. Robinson, K. Jarvie, 1994, Molecular pharmacology.

Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor.

M. Caron, R. Fremeau, J. Gingrich, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Discovery and characterization of AZD9272 and AZD6538-Two novel mGluR5 negative allosteric modulators selected for clinical development.

P. Raboisson, David Wensbo, A. Slassi, 2012, Bioorganic & medicinal chemistry letters.

Pharmacological Characterization of the Competitive GLUK5 Receptor Antagonist Decahydroisoquinoline LY466195 in Vitro and in Vivo

David Bleakman, Kirk W. Johnson, Andrew Alt, 2006, Journal of Pharmacology and Experimental Therapeutics.

Silencing of the Constitutive Activity of the Dopamine D1B Receptor

M. Caron, D. M. Severynse, K. Jarvie, 1996, The Journal of Biological Chemistry.

The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques

A. Lang, J. Brotchie, P. Seeman, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.

K. Jarvie, J. Arora, A. Tehim, 2005, Bioorganic & medicinal chemistry letters.

Glycoprotein nature of D2 dopamine receptors

P. Seeman, H. Niznik, D. Grigoriadis, 1988, FEBS letters.

Design and synthesis of a novel series of 1,2-disubstituted cyclopentanes as small, potent potentiators of 2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic acid (AMPA) receptors.

G. Stephenson, D. Bleakman, B. Cantrell, 2002, Journal of medicinal chemistry.

A photoaffinity label for the D-1 dopamine receptor, (RS)-7-[125I]Iodo-8-hydroxy-3-methyl-1-(4'-azidophenyl)-2,3,4,5- tetrahydro-1H-3-benzazepine, selectively identifies the ligand binding subunits of the receptor.

P. Seeman, H. Niznik, J. Neumeyer, 1988, Journal of medicinal chemistry.

Heterogeneity of dopamine receptors.

M. Caron, K. Jarvie, Marc G. Caron, 1993, Advances in neurology.

Photoaffinity labeling of dopamine D1 receptors.

P. Seeman, H. Niznik, J. Neumeyer, 1988, Biochemistry.

Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro

P. Ornstein, D. Bleakman, D. Zimmerman, 2001, Neuropharmacology.

Dopamine D-2 receptors in canine brain: ionic effects on [3H]neuroleptic binding.

P. Seeman, H. Niznik, K. Jarvie, 1987, European journal of pharmacology.

Dopamine D1 receptors of the calf parathyroid gland: identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1-receptors.

H. Niznik, K. Jarvie, E. M. Brown, 1989, Biochemistry.

Reactivity of normal and VMH-lesion rats to quinine-adulterated foods: negative evidence for negative finickiness.

H. Weingarten, K. Jarvie, P. Chang, 1983, Behavioral neuroscience.

Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000.

P. Seeman, H. Niznik, K. Jarvie, 1988, Molecular pharmacology.

Molecular cloning, stable expression and desensitization of the human dopamine D1b/D5 receptor.

M. Caron, J. Gingrich, K. Jarvie, 1993, Journal of receptor research.

N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists.

K. Jarvie, Nancy Barriault, J. Arora, 2004, Bioorganic & medicinal chemistry letters.

Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.

H. Niznik, K. Jarvie, G. Booth, 1989, Molecular Pharmacology.

Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.

P. Ornstein, D. Bleakman, B. Cantrell, 2000, Journal of medicinal chemistry.

Cloning of two additional catecholamine receptors from rat brain

P. Seeman, H. Niznik, Y. Israel, 1990, FEBS letters.